1.300
+0,00%
2026-10-16
Fundamental Analysis
50 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -0.3% | -5.7% | 1 / 3 | +42.0% | +43.34 pp | +33.10 pp | -13.5% | 1.17 | — | 3,0 | +42,0% | −2,4 | −0,3% | — | -1.88 | — |
| Pts | 0 | 0 | 4 | 12 | 12 | 12 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 1.300 (close price on 2026-10-16)EPS (TTM): −663,3
Financial charts
1.Revenue & growth
VND bn3,02Q2/26
1.Revenue & growth
VND bn3,02Q2/26
2.Profit & growth
VND bn-2,47Q2/26
3.Profit mix (Penman)
VND bn-10,7Q2/26
4.Margins & cost structure
%-8.4%Q2/26
5.Returns & cash cycle
% · days-1.3%Q2/26
6.Earnings quality & cash
VND bn1,34Q2/26
7.Asset structure
VND bn197Q2/26
8.Funding & debt health
VND bn · times197Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %-1,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-154Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26